SCHEMBL6982281

SCHEMBL6982281

CC(C)Oc1ccc(C=O)cc1[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.55
ALDH5A1 P51649 1/20 0.53
ABAT P80404 1/20 0.53
VCAM1 P19320 1/20 0.53
TTR P02766 1/20 0.50
ALDH3A1 P30838 2/20 0.49
ALDH1A1 P00352 7/20 0.48
LMNA P02545 4/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPT P10636 6/20 0.47
HPGD P15428 4/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28918509 0.88 ALDH5A1 (0.50) ALDH5A1ABATVCAM1TTRALDH3A1
SCHEMBL15283778 0.88 ALDH1A1 (0.50) PDK1ALDH5A1ABATVCAM1TTR
SCHEMBL16958496 0.86 PDK1 (0.53) PDK1ALDH5A1ABATVCAM1TTR
SCHEMBL16961250 0.86 PDK1 (0.57) PDK1ALDH5A1ABATTTRALDH1A1
SCHEMBL1414763 0.84 ALDH5A1 (0.53) ALDH5A1ABATVCAM1TTRALDH3A1
SCHEMBL531831 0.84 ALDH5A1 (0.50) PDK1ALDH5A1ABATVCAM1TTR
SCHEMBL28115845 0.83 ALDH3A1 (0.49) PDK1ALDH5A1ABATVCAM1TTR
SCHEMBL2559542 0.83 GRIN2D (0.49) PDK1ALDH5A1ABATVCAM1TTR
SCHEMBL531886 0.82 ALDH5A1 (0.48) PDK1ALDH5A1ABATVCAM1TTR
SCHEMBL5350350 0.82 ALDH5A1 (0.48) PDK1ALDH5A1ABATVCAM1TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1437587-A Benzoxazepinones and their use as squalene synthetase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-08-20 CN disclosed
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors TAKEDA CHEMICAL INDUSTRIES LTD. (JP) 2003-04-24 US disclosed
EP-1292585-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
WO-2001098282-A1 BENZOXAZEPINONES AND THEIR USE AS SQUALENE SYNTHASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 2001-12-27 WO disclosed
US-4948796-A TREATING CEREBO-VASCULARE DISEASES TOYAMA CHEMICAL CO., LTD. (JP) 1990-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078251-A1 Benzoxazepinones and their use as squalene synthase inhibitors SQLE, CYP17A1, ACOX1 PDK1 2995/4885ALDH5A1 1356/4885ABAT 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.